This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Toyama Chemical Co., Ltd., Armonicos Co., Ltd., Nic Autotec, Inc.. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: Hiroshi Nishikawa: Innovator in Pharmaceutical Composition
Introduction
Hiroshi Nishikawa is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents. With a total of 3 patents, his work has been instrumental in advancing therapeutic methods for fungal infections.
Latest Patents
Nishikawa's latest patents focus on pharmaceutical compositions that utilize antifungal agents in combination with other therapeutic agents. One of his notable inventions is a pharmaceutical composition containing an arylamidine derivative, which exhibits strong antifungal activity. This composition is particularly useful for treating fungal infections and skin diseases such as atopic dermatitis. Another patent involves a phenylamidine derivative, which, when used in combination with various antifungal agents, proves effective against fungal pathogens. These innovations highlight his commitment to improving treatment options for patients suffering from fungal infections.
Career Highlights
Throughout his career, Hiroshi Nishikawa has worked with prominent companies in the pharmaceutical industry, including Toyama Chemical Co., Ltd. and Nic Autotec, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and formulation.
Collaborations
Nishikawa has collaborated with esteemed colleagues such as Masahiro Akiyama and Nobuhiko Nomura. These partnerships have contributed to the success of his research and the advancement of his patented technologies.
Conclusion
Hiroshi Nishikawa's innovative work in pharmaceutical compositions has made a significant impact on the treatment of fungal infections. His contributions continue to influence the field and provide valuable therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile